1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALKERMES PLC
Alkermes plc XNAS: ALKS

Alkermes PLC Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to ...

Read More
31.91 -0.09 (-0.28%)
26.83% Gain from 52W Low
1.8M
XNAS Volume

XNAS 20 Feb, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Alkermes PLC is on 25 Feb 2026 for the purpose of Alkermes PLC Annual Report for 2025 See details
Durability score
High Financial Strength
72.2 / 100
Valuation Score
Mid Valuation
47.5 / 100
Momentum Score
Technically Neutral
58.9 / 100
Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM
Analyst Price Target
44
1Yr Price target upside is 37%
16 analysts

9

S

11

W

6

O

0

T

SWOT Analysis

Alkermes PLC Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..